Based on the Geron Corporation stock forecast from 6 analysts, the average analyst target price for Geron Corporation is USD 6.90 over the next 12 months. Geron Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Geron Corporation is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Geron Corporation’s stock price was USD 3.49. Geron Corporation’s stock price has changed by -9.59% over the past week, -12.53% over the past month and +61.57% over the last year.
No recent analyst target price found for Geron Corporation
No recent average analyst rating found for Geron Corporation
Company Overview Geron Corporation
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California. Read Less
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontr...Read More
Frequently Asked Questions About Geron Corporation (GERN) Stock
Based on ratings from 6 analysts Geron Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and hold ratings.
Unfortunately we do not have enough data on GERN's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for GERN is USD 6.90 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 6.
Unfortunately we do not have enough data on GERN's stock to indicate if its overvalued.
The last closing price of GERN's stock was USD 3.49.
The most recent market capitalization for GERN is USD 2.37B.
Based on targets from 6 analysts, the average taret price for GERN is projected at USD 6.90 over the next 12 months.
This means that GERN's stock price may go up by +97.71% over the next 12 months.
We can't find any ETFs which contains Geron Corporation's stock.
As per our most recent records Geron Corporation has 141 Employees.
Geron Corporation's registered address is 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404.
You can get more information about it from Geron Corporation's website at https://www.geron.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Geron Corporation (GERN) Stock
Based on ratings from 6 analysts Geron Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and hold ratings.
Unfortunately we do not have enough data on GERN's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for GERN is USD 6.90 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 6.
Unfortunately we do not have enough data on GERN's stock to indicate if its overvalued.
The last closing price of GERN's stock was USD 3.49.
The most recent market capitalization for GERN is USD 2.37B.
Based on targets from 6 analysts, the average taret price for GERN is projected at USD 6.90 over the next 12 months.
This means that GERN's stock price may go up by +97.71% over the next 12 months.
We can't find any ETFs which contains Geron Corporation's stock.
As per our most recent records Geron Corporation has 141 Employees.
Geron Corporation's registered address is 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404.
You can get more information about it from Geron Corporation's website at https://www.geron.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GERN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
